Ralmitaront
5-ethyl-4-methyl-N-[4-[(2S)-morpholin-2-yl]phenyl]-1H-pyrazole-3-carboxamide
Molecular Identity
Ralmitaront
5-ethyl-4-methyl-N-[4-[(2S)-morpholin-2-yl]phenyl]-1H-pyrazole-3-carboxamide
PubChem CID: 130429734
2D Structure
Properties
C17H22N4O2
Molecular Formula
314.40
Molecular Weight
g/mol
314.1743
Exact Mass
Da
1.6
XLogP
Drug-like (Lipinski: < 5)
79
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
4
H-Bond Acceptors
398
Complexity
SMILES
Canonical SMILES
SMILES: CCC1=C(C(=NN1)C(=O)NC2=CC=C(C=C2)C3CNCCO3)CIsomeric SMILES
SMILES: CCC1=C(C(=NN1)C(=O)NC2=CC=C(C=C2)[C@H]3CNCCO3)CSynonyms(20)
Ralmitaront2133417-13-5Ralmitaront [INN]Ralmitaront [USAN]RG7906QA8MW1Q80PRO6889450RG-7906RO-6889450RALMITARONT [WHO-DD]5-Ethyl-4-methyl-N-[4-[(2S)-morpholin-2-yl]phenyl]-1H-pyrazole-3-carboxamideDTXSID9013369761H-Pyrazole-3-carboxamide, 5-ethyl-4-methyl-N-(4-(2S)-2-morpholinylphenyl)-Example 1 [WO2017157873A1]5-Ethyl-4-methyl-N-{4-[(2S)-morpholin-2-yl]phenyl}-1H-pyrazole-3-carboxamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Ralmitaront
Loading drug network...